Are targeted therapies really targeted?
作者信息
Schilsky Richard L
机构信息
University of Chicago, IL, USA.
出版信息
Clin Adv Hematol Oncol. 2003 Dec;1(12):722-3.
PMID:16258475
Abstract
摘要
相似文献
1
Are targeted therapies really targeted?
Clin Adv Hematol Oncol. 2003 Dec;1(12):722-3.
2
Developing targeted therapies for lung cancer.
Clin Adv Hematol Oncol. 2003 Nov;1(11):648-9, 690.
3
Immunotoxin therapy of malignancy.
Important Adv Oncol. 1992:111-35.
4
Targeted therapies: aiming for the bull's-eye.
ONS Connect. 2007 Jul;22(7):8-12.
5
The development of molecularly targeted anticancer therapies: an Eli Lilly and Company perspective.
Clin Adv Hematol Oncol. 2005 Mar;3(3):199-202, 237-8.
6
Antibody-drug conjugates for cancer: poised to deliver?
Nat Rev Drug Discov. 2010 Sep;9(9):665-7. doi: 10.1038/nrd3270.
7
Clinical trial design and end points for epidermal growth factor receptor-targeted therapies: implications for drug development and practice.
Clin Cancer Res. 2003 May;9(5):1579-89.
8
Targeted cancer therapy: conferring specificity to cytotoxic drugs.
Acc Chem Res. 2008 Jan;41(1):98-107. doi: 10.1021/ar700108g. Epub 2007 Aug 18.
9
A dose of reality for rational therapies.
Nat Biotechnol. 2005 Mar;23(3):267. doi: 10.1038/nbt0305-267.
10
[The pathologist and targeted therapies in oncology].
Ann Pathol. 2009 Nov;29 Spec No 1:S69-70. doi: 10.1016/j.annpat.2009.07.035.
Zotero 插件